|
|
Lolo... I think your statistics are a bit off.
I apologize for the simplified statistics. Following is some more detailed information about the strains of HPV, their effects and the risks involved.
However, I think it's important to note that medical literature does not precisely say that HPV causes cancer... rather, most cervical cancer cases will show HPV 16 or 18 to be present as well.
Please note the first few lines of the following information.
Human Papilloma Virus Testing in Cervical Cancer Prevention (I had to link to the Google search for the website b/c using the link to the direct page requires user name and password. Choose the second link on Google with the name of the above link.)
Almost all strains of HPV that infect the anogenital tract are capable of causing abnormal cervical cytology. A clear causal relationship has been established between HPV infection and cervical cancer, and HPV is found in nearly 100% of cervical malignancies worldwide. This link is the highest attributable fraction ever identified for a specific cause of a major human cancer worldwide. The latency period between initial HPV exposure and development of cervical cancer may be months to years. Although rapid progression is possible, average time from initial infection to manifestation of invasive cervical cancer is estimated at up to 15 years.
Genital HPV strains are divided into two groups, based on their oncogenic potential and ability to induce viral-associated tumors. Certain strains termed "high-risk strains" (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68) are associated with intraepithelial neoplasia and are more likely to progress to severe lesions and cancer. Of these, HPV 16 and 18 are the most carcinogenic and most prevalent. HPV 16 is the predominant strain in almost all regions of the world, with the exception of Southeast Asia, where HPV 18 has the highest prevalence. HPV 16 alone accounts for more than 50% of HPV infections, and it is estimated that almost 20% of American women are infected. High-grade cervical intraepithelial lesions are most commonly associated with HPV 16 and 18, yet these strains are also frequently found to be the etiologic factor in minor lesions and mild dysplasia.
Low-risk strains (HPV 6, 11, 42, 43, and 44) are associated with condylomata and low-grade cervical changes, such as mild dysplasia. Lesions due to low-risk HPV infection have a high likelihood of regression, little potential for progression, and are considered of no or low oncogenic risk. It is hypothesized that the different high- and low-risk HPV strains exert varying degrees of transmissibility, yet no clear data exist to define this parameter of infection.
Despite the significant correlation between high-risk HPV and cervical cancer, 80% of infections are transient, asymptomatic, and resolve without treatment (Figure 1). When this occurs, HPV-related cervical intraepithelial lesions spontaneously regress, and HPV is no longer detectable in the cervix…. Median duration of locally detectable HPV infection ranges from 6 to 14 months. Within 2 to 4 years, only 15% to 25% of low-grade cervical intraepithelial lesions progress to high-grade severity. Persistent high-risk HPV infection is the key attribute of high-grade cervical disease.
Prevalence of HPV is greatest in young, sexually active individuals. For women, prevalence peaks in the 20- to 24-year-old age group, with estimates as high as 50%. The 15- to 19-year-old age group has the next highest rates of HPV infection.
HPV in adolescents is frequently short-lived and spontaneously regressive, whereas infection in older women tends to persist.
And when it does lead to cancer, it is a very slowly progressing and treatable cancer.
This is not to downplay the importance of the vaccine, but I think there is a tendency to overblow the risks of HPV, while many gynecologists believe that generally the virus is about as common, and about as dangerous, as the common cold.
This does downplay the importance of the vaccine. How many common colds can lead to hysterectomies? Not to be doom and gloom here, but have a look at this website which discusses treatment options for cervical cancer.
Which surgery for cervical cancer?
Note that early cervical cancer treatment includes hysterectomy. Who wants a “very slowly progressing and treatable cancer”? The “treatments” are not pleasant options. Why risk not getting the vaccine? If a woman is living her life based on odds, on dice, there really isn’t any fore-thought or calculated safety involved. And if one is a male, he shouldn’t advise a woman to play her life as if it is a roulette game.
Do you have a medical problem with the vaccine itself?
In addition, it's my personal feeling that LEEP procedures are pushed too aggressively in the US.
As far as LEEP being aggressively pushed, that’s a totally different issue. Receiving a LEEP depends largely on the woman’s desires, concerns and level of personal research and understanding of her own condition. If her reports are showing CIN 2 or CIN 3, it would probably be wise to consider the procedure. Also remember that a doctor has a requirement to minimize risk of death, and that should be taken into consideration as a reason for why LEEP is strongly suggested. It is the woman’s ultimate responsibility to ask where her risk lies, and it is her decision how she wants to proceed with her own physical health. |
|
|